Name | Number of supported studies | Average coverage | |
---|---|---|---|
lung | 19 studies | 43% ± 14% | |
peripheral blood | 18 studies | 31% ± 9% | |
intestine | 9 studies | 31% ± 11% | |
kidney | 9 studies | 30% ± 8% | |
brain | 8 studies | 30% ± 12% | |
liver | 7 studies | 31% ± 17% | |
uterus | 5 studies | 49% ± 12% | |
pancreas | 4 studies | 41% ± 13% | |
placenta | 4 studies | 59% ± 21% | |
bone marrow | 4 studies | 27% ± 10% | |
prostate | 4 studies | 43% ± 14% | |
skin | 4 studies | 44% ± 12% | |
lymph node | 4 studies | 34% ± 16% | |
breast | 4 studies | 41% ± 3% | |
eye | 3 studies | 43% ± 18% | |
heart | 3 studies | 24% ± 4% | |
adipose | 3 studies | 33% ± 7% | |
adrenal gland | 3 studies | 38% ± 7% | |
thymus | 3 studies | 33% ± 13% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 9306.62 | 1444 / 1445 | 100% | 125.21 | 183 / 183 |
lung | 100% | 18850.41 | 578 / 578 | 100% | 137.07 | 1154 / 1155 |
ovary | 100% | 8128.12 | 180 / 180 | 100% | 87.95 | 429 / 430 |
skin | 100% | 10047.72 | 1803 / 1809 | 100% | 791.87 | 472 / 472 |
breast | 100% | 16941.22 | 459 / 459 | 100% | 133.42 | 1113 / 1118 |
brain | 99% | 8159.59 | 2622 / 2642 | 100% | 153.51 | 704 / 705 |
thymus | 100% | 10135.37 | 651 / 653 | 99% | 95.51 | 600 / 605 |
uterus | 100% | 9666.35 | 170 / 170 | 99% | 108.63 | 453 / 459 |
prostate | 100% | 6519.84 | 244 / 245 | 99% | 101.33 | 497 / 502 |
kidney | 100% | 7909.43 | 89 / 89 | 98% | 127.82 | 883 / 901 |
adrenal gland | 100% | 10220.36 | 258 / 258 | 98% | 104.54 | 225 / 230 |
intestine | 100% | 10237.38 | 966 / 966 | 98% | 127.34 | 515 / 527 |
stomach | 100% | 8534.16 | 358 / 359 | 98% | 123.34 | 280 / 286 |
bladder | 100% | 10535.95 | 21 / 21 | 97% | 105.64 | 487 / 504 |
liver | 89% | 3936.04 | 201 / 226 | 97% | 87.26 | 393 / 406 |
pancreas | 83% | 3426.95 | 271 / 328 | 99% | 145.69 | 176 / 178 |
adipose | 100% | 22380.28 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 857.74 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 139.00 | 29 / 29 |
spleen | 100% | 16934.93 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 31.04 | 1 / 1 |
blood vessel | 100% | 10689.66 | 1334 / 1335 | 0% | 0 | 0 / 0 |
peripheral blood | 98% | 33438.34 | 915 / 929 | 0% | 0 | 0 / 0 |
heart | 98% | 7641.63 | 841 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 96% | 76.84 | 43 / 45 |
muscle | 88% | 3540.39 | 707 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0042327 | Biological process | positive regulation of phosphorylation |
GO_0030511 | Biological process | positive regulation of transforming growth factor beta receptor signaling pathway |
GO_0007265 | Biological process | Ras protein signal transduction |
GO_0030307 | Biological process | positive regulation of cell growth |
GO_0046330 | Biological process | positive regulation of JNK cascade |
GO_0006612 | Biological process | protein targeting to membrane |
GO_0000122 | Biological process | negative regulation of transcription by RNA polymerase II |
GO_1903543 | Biological process | positive regulation of exosomal secretion |
GO_0030036 | Biological process | actin cytoskeleton organization |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0030335 | Biological process | positive regulation of cell migration |
GO_0006930 | Biological process | substrate-dependent cell migration, cell extension |
GO_0007268 | Biological process | chemical synaptic transmission |
GO_0007346 | Biological process | regulation of mitotic cell cycle |
GO_0099054 | Biological process | presynapse assembly |
GO_0010718 | Biological process | positive regulation of epithelial to mesenchymal transition |
GO_0008284 | Biological process | positive regulation of cell population proliferation |
GO_0002091 | Biological process | negative regulation of receptor internalization |
GO_1903553 | Biological process | positive regulation of extracellular exosome assembly |
GO_0035578 | Cellular component | azurophil granule lumen |
GO_0005615 | Cellular component | extracellular space |
GO_0098793 | Cellular component | presynapse |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005576 | Cellular component | extracellular region |
GO_0005886 | Cellular component | plasma membrane |
GO_0045121 | Cellular component | membrane raft |
GO_0016020 | Cellular component | membrane |
GO_0005789 | Cellular component | endoplasmic reticulum membrane |
GO_1903561 | Cellular component | extracellular vesicle |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005925 | Cellular component | focal adhesion |
GO_0072562 | Cellular component | blood microparticle |
GO_0005895 | Cellular component | interleukin-5 receptor complex |
GO_0005829 | Cellular component | cytosol |
GO_0005912 | Cellular component | adherens junction |
GO_0005737 | Cellular component | cytoplasm |
GO_0031965 | Cellular component | nuclear membrane |
GO_0042470 | Cellular component | melanosome |
GO_0005634 | Cellular component | nucleus |
GO_0046875 | Molecular function | ephrin receptor binding |
GO_0044877 | Molecular function | protein-containing complex binding |
GO_0005546 | Molecular function | phosphatidylinositol-4,5-bisphosphate binding |
GO_0005109 | Molecular function | frizzled binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0045545 | Molecular function | syndecan binding |
GO_0042043 | Molecular function | neurexin family protein binding |
GO_0019838 | Molecular function | growth factor binding |
GO_0050839 | Molecular function | cell adhesion molecule binding |
GO_0035255 | Molecular function | ionotropic glutamate receptor binding |
GO_0046982 | Molecular function | protein heterodimerization activity |
GO_0005137 | Molecular function | interleukin-5 receptor binding |
GO_0140311 | Molecular function | protein sequestering activity |
GO_0008093 | Molecular function | cytoskeletal anchor activity |
GO_0005515 | Molecular function | protein binding |
Gene name | SDCBP |
Protein name | Syndecan binding protein Syndecan binding protein (cDNA FLJ55055, moderately similar to Syntenin-1) Syntenin-1 (Melanoma differentiation-associated protein 9) (MDA-9) (Pro-TGF-alpha cytoplasmic domain-interacting protein 18) (TACIP18) (Scaffold protein Pbp1) (Syndecan-binding protein 1) |
Synonyms | hCG_1787561 SYCL MDA9 |
Description | FUNCTION: Multifunctional adapter protein involved in diverse array of functions including trafficking of transmembrane proteins, neuro and immunomodulation, exosome biogenesis, and tumorigenesis . Positively regulates TGFB1-mediated SMAD2/3 activation and TGFB1-induced epithelial-to-mesenchymal transition (EMT) and cell migration in various cell types. May increase TGFB1 signaling by enhancing cell-surface expression of TGFR1 by preventing the interaction between TGFR1 and CAV1 and subsequent CAV1-dependent internalization and degradation of TGFR1 . In concert with SDC1/4 and PDCD6IP, regulates exosome biogenesis . Regulates migration, growth, proliferation, and cell cycle progression in a variety of cancer types . In adherens junctions may function to couple syndecans to cytoskeletal proteins or signaling components. Seems to couple transcription factor SOX4 to the IL-5 receptor (IL5RA) . May also play a role in vesicular trafficking . Seems to be required for the targeting of TGFA to the cell surface in the early secretory pathway . . |
Accessions | ENST00000447182.6 [O00560-2] ENST00000447267.4 ENST00000413219.6 [O00560-1] O00560 ENST00000520168.5 E9PBU7 ENST00000630925.1 ENST00000424270.6 [O00560-3] B4DHN5 ENST00000523483.5 ENST00000260130.9 [O00560-1] G5EA09 |